Tag Archives: investigational medicines

Roche to present 60 abstracts featuring nine of its approved or investigational medicines at the 58th American Society of Hematology (ASH) in San Diego

New results from the phase III GALLIUM study which compared Gazyva/Gazyvaro (obinutuzumab) plus chemotherapy to Rituxan/ MabThera (rituximab) plus chemotherapy in previously untreated follicular lymphoma will be presented in the Plenary Scientific Session New results for Venclexta/Venclyxto(venetoclax) and investigational medicine … Read the full press release

Roche to present 19 approved and investigational medicines at American Society of Clinical Oncology (ASCO) Annual Meeting, 3rd – 7th June in Chicago

19 Roche medicines are included in more than 200 abstracts during ASCO 2016 New results for cancer immunotherapy atezolizumab in bladder cancer and other cancer types Early results for atezolizumab in combination with targeted medicines and the investigational cancer immunotherapy … Read the full press release